Jan 28 (Reuters) - Regenxbio said on Wednesday the U.S. Food and Drug Administration has placed a clinical hold on two of its ...
A central nervous system (CNS) tumor has prompted the FDA to place clinical holds on two Regenxbio gene therapies, including ...
GlobalData on MSN
FDA puts REGENXBIO gene therapy trials on hold after brain tumour
A five-year-old patient dosed with RGX-111 has developed a brain tumour four years after being dosed with the gene therapy.
The development of a brain tumor in a study participant led regulators to suspend a Hurler syndrome therapy in early testing ...
The U.S. Food and Drug Administration (FDA) is celebrating a historic milestone in 2026, marking 120 years of national ...
The Food and Drug Administration paused trials for two experimental gene therapies from Regenxbio after one child developed a ...
ByHeart makes up about 1% of the U.S. formula market and sold roughly 200,000 cans per month. The product, which costs about ...
FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
Murmur has received FDA 510(k) clearance for its next-generation heart murmur detection software, eMurmur Heart AI (2.2).
Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...
FDA issues a safety alert for MediHoney and CVS Wound Gel products due to packaging failures that may compromise sterility and cause infection.
By Kamal Choudhury Jan 27 (Reuters) - Intellia Therapeutics said on Tuesday that the U.S. drug regulator has lifted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results